Generate a tailored SOP for Dr. Henrieta Scholtzova. Improve your application with a focused, well-structured draft.
Henrieta Scholtzova is an Associate Professor in the Department of Neurology, focusing on Alzheimer's disease (AD) and cognitive impairment. Her research emphasizes modulating immune cell function to mitigate AD pathology through innate immunity stimulation. She has pioneered translational research utilizing non-human primate models that closely mimic human features of AD, particularly cerebral amyloid angiopathy (CAA). Her contributions have laid the foundation for critical preclinical clinical applications, including a Phase 1 Clinical Trial on TLR9 agonist therapies. Ongoing projects investigate neuroimaging techniques to detect AD-related pathology and assess brain tissue integrity. Scholtzova is dedicated to understanding CAA-related complications, responding to the increasing prevalence of patients receiving new AD therapies. Through comprehensive longitudinal studies, she aims to advance the field of Alzheimer's research, contributing valuable insights into effective interventions.
Open Program in Biomedical Sciences (Vilcek Institute) covers departments like Biochemistry, Pathology, Neuroscience, Microbiology, etc.